Orion OYJ (OTCMKTS:ORINY) Sees Large Volume Increase – What’s Next?

Shares of Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) saw unusually-high trading volume on Friday . Approximately 1,086 shares were traded during mid-day trading, an increase of 92% from the previous session’s volume of 567 shares.The stock last traded at $45.7650 and had previously closed at $45.25.

Orion OYJ Stock Performance

The stock has a 50-day moving average of $41.33 and a 200 day moving average of $39.72. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.64 and a quick ratio of 1.48. The stock has a market capitalization of $12.92 billion, a price-to-earnings ratio of 18.83 and a beta of 0.07.

Orion OYJ (OTCMKTS:ORINY) last released its earnings results on Friday, July 17th. The company reported $0.58 earnings per share (EPS) for the quarter. Orion OYJ had a net margin of 28.52% and a return on equity of 50.37%. The company had revenue of $606.38 million for the quarter.

Orion OYJ Company Profile

Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research.

Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France.